shown by gel filtration to be smaller than the chondroitin 4-sulphate in the media of these cultures. This discovery of relatively high proportions of chondroitin 4-sulphate in these mastocytoma-derived cells is noteworthy, since mast cells have generally been considered to produce heparin as their major glycosaminoglycan.
Biosynthesis of glycosaminoglycans by several lines of cultured neoplastic mouse mast cells was studied by incorporation of [35S] sulphate (and in some cases [6-3H] glucosamine) into macromolecular materials found in both the cells and their growth media. Such intracellular and extracellular radioactively labelled materials (shown to be glycosaminoglycans by susceptibility to digestion with heparinase) were further characterized by ion-exchange chromatography and by digestion with testicular hyaluronidase and chondroitinase. All shown by gel filtration to be smaller than the chondroitin 4-sulphate in the media of these cultures. This discovery of relatively high proportions of chondroitin 4-sulphate in these mastocytoma-derived cells is noteworthy, since mast cells have generally been considered to produce heparin as their major glycosaminoglycan.
Glycosaminoglycans are synthesized as a special function of differentiated connective-tissue cells for export to the extracellular matrix or for storage in intracellular granules. In addition, recent studies have shown that many cell types (not just highly differentiated ones of a connective-tissue origin) can synthesize smaller amounts of sulphated glycosaminoglycans (Kraemer, 1971a,b; Dietrich & Montes DeOca, 1970; Bates & Levene, 1971; Suzuki et al., 1970) . Some of these glycosaminoglycans have been reported to be found in the cell membranes (Kraemer, 1971a) . The possible importance to the cell of such membranebound glycosaminoglycans is suggested by recent studies (Suzuki et al., 1970) which have shown that the surface charge of certain types can be markedly altered by treatment with glycosaminoglycan-degrading enzymes. This laboratory has initiated an investigation of the cellular metabolism of glycosaminoglycans and the possible role of these substances in cell structure. For such studies it was decided to use cell cultures in vitro. A search was begun for cell lines satisfying several criteria: (1) cultures should be homogeneous; (2) cells must have glycosaminoglycan-synthesizing activity great enough to be experimentally useful; (3) such cells should be able to be grown easily in quantities large enough to permit the preparation of subcellular fractions.
Several long-established cell lines derived from mouse mastocytomas were available and offered promise of satisfying the necessary criteria. Some of Vol. 134 these cell lines have previously been used for studies of heparin biosynthesis (Green & Day, 1960) as well as for other cellular studies including those of Green & Day (1963) , Wheldrake & Pasternak (1968) , Pasternak & Bergeron (1970) and Thomas (1968) . We report here the results of a survey of several longestablished and newly derived mouse mastocytoma cell lines. The biosynthesis of glycosaminoglycans by cells of these mastocytoma lines was analysed both quantitatively and qualitatively. The accompanying paper (Lewis et al., 1973) (Fischer & Sartorelli, 1964) supplemented with horse serum was used. For special studies, the F-12 medium of Ham (1965) and MEM medium of Eagle (1959) were used with supplements of horse serum or foetal calf serum. No antibiotics were added to the cultures at any time. The flasks were maintained in an environment of CO2 +air (5:95) at 37°C. Mastocytoma cells do not adhere to the flask surface; therefore the cells could be subcultured twice weekly by agitating the culture and transferring portions of the resulting suspension by using an approx. 1:200 (v/v) transfer ratio. Mastocytoma cells grown in this manner had a mean generation time of 10-12h. This technique of culturing mastocytoma cells in tissue-culture flasks, rather than in culture tubes, allowed for more efficient gas exchange between culture liquid and culture gas phases.
Cell sources. The following established cell lines were used: P815Y (X-2) and X163 (subline of X-1) clonally derived by Schindler et al. (1959) from the Dunn-Potter mouse mastocytoma (Dunn & Potter, 1957) , and HC73 (Mannaioni et al., 1965) clonally derived from the Furth-Hagen-Hirsch mouse mastocytoma (Furth et al., 1957) . These [6_3H]glucosamine (20 x106c.p.m.) was also added.
After 3 days' growth, the cells were separated from the growth medium by centrifugation (400g).
The combined cells from two flasks were washed four times by centrifugation (400g) with phosphatebuffered saline (Dulbecco & Vogt, 1954) and then homogenized in 5ml of water with a Teflon PotterElvehjem homogenizer. Complete cell disruption was observed after approximately 30s at a speed of 1-2000rev./min. Samples were analysed for cell protein.
The homogenates were then boiled and incubated in 0.05M-Tris buffer, pH9.0, at 37°C with 1 mg of pancreatin. Several drops of toluene were added to retard bacterial growth. After the first day of incubation, the pancreatin and toluene were replenished. Total incubation period was 2-3 days. The combined growth medium from two flasks was boiled and incubated with pancreatin (10mg) in a manner similar to that used with the cell homogenates.
After incubation with pancreatin, samples were boiled and centrifuged at 20000g for 30min. The supernatants resulting from the centrifugation of both the cellular and medium materials were then dialysed against water to remove radioactive sulphate. In some experiments, the supematant preparations were chromatographed on a column (3cm x 25cm) of Sephadex G-25. Removal of sulphate and recovery ofmacromolecular material were essentially the same whether gel filtration or dialysis was used.
In all cases, 35S-labelled macromolecular material was shown to be exclusively glycosaminoglycan. This 1973 was demonstrated by its total digestion with heparinase preparations, as described below. Glycosaminoglycan characterization. Radioactively labelled glycosaminoglycans were incubated with testicular hyaluronidase, Flavobacterium heparinase and chondroitinase ABC. The hyaluronidase reaction mixtures in a volume of 0.2ml contained 0.5mg of hyaluronidase, 0.1 M-sodium acetate buffer (pH 5.0), 0.05M-NaCl and 5mg of chondroitin 4-sulphate and were incubated overnight at 37°C. The heparinase reaction mixtures in a volume of 0.2ml contained 0.5mg of heparinase, 0.1 M-sodium acetate buffer (pH6.0) and 1mg of chondroitin sulphate or heparin and were incubated overnight at 22°C. The chondroitinase reaction mixtures in a volume of0.2ml contained 0.02ml of 'Tris mixture' , 0.12mg of standard chondroitin 4-sulphate, 0.12mg of standard chondroitin 6-sulphate and 0.5 unit of chondroitinase ABC and were incubated for 1 h at 37°C.
After incubation, the hyaluronidase and heparinase reaction mixtures were boiled for 10min and NaCl was added to a final concentration of 1 M. Samples were placed on columns (1 cm x 15cm) of Sephadex G-50 and eluted with lM-NaCl. The radioactivity and uronic acid content of samples of the fractions were determined. The amount of material appearing in the included fractions was considered to represent the degraded material.
After incubation with chondroitinase, entire reaction mixtures were spotted on Whatman no. 1 paper and chromatographed overnight with butan-lol-acetic acid-1 M-aq. NH3 (2: 3:1, by vol.). Chromatograms were cut into strips and eluted with water. Portions of the eluate were assayed for radioactivity and uronic acid. Alternatively, the positions of the carrier disaccharides were determined by scanning the chromatograms with u.v. light.
Labelled glycosaminoglycans were separated on the basis of charge densities by ion-exchange chromatography. The resin (DEAE-cellulose) was precycled and equilibrated with water. Samples were placed on columns (1cm x 3cm) with 2mg of hyaluronic acid, 5mg of chondroitin sulphate and 5mg of heparin as standards. Materials were eluted with a logarithmic gradient by using a 125 ml mixing chamber and a reservoir of 1 M-LiCl, followed by a reservoir of 2M-LiCl solution, as previously described (Silbert & DeLuca, 1969) . Fractions (2.5ml) were collected and analysed for radioactivity, uronic acid content and (in some cases) hexosamine content.
Molecular size was estimated by chromatography on columns (1 cmx 60cm) of Sepharose 4B by a method similar to that of Wasteson (1971) , by using chondroitin 6-sulphate (mol.wt. 40000, as determined by the manufacturer) as the standard. Blue Dextran 2000 and Phenol Red solutions were used to determine the void (V0) and included (VI) volumes reVol. 134 spectively. The eluent was 0.1 M-LiCl and fractions (1 ml) were collected. Portions of the fractions were assayed for radioactivity and uronic acid content.
The effects of alkali on the pancreatin-solubilized glycosaminoglycans were determined by incubation of the preparations with 0.1 M-NaOH overnight at 4°C. After neutralization, the alkali-treated samples were chromatographed on Sepharose columns as described above.
Analytical methods
Uronic acid content of chromatographic fractions was determined by the Bitter & Muir (1962) technique. The sulphate content of the growth medium was determined by using the procedure of Letonoff & Reinhold (1936) . The protein content of the cell homogenates was determined by the procedure of Lowry et al. (1951) , with bovine serum albumin as standard. The procedure used for amino sugar characterization was essentially the chromatographic technique of Gardell (1953) , the colorimetric method of Levvy & McAllan (1959) being used for hexosamine assay.
For most experiments, an Ansitron liquid-scintillation spectrometer was used to determine radioactivity by using the scintillation fluid of Bray (1960 In all three cases, more 3"S-labelled glycosaminoglycan was found within the cells than in the growth medium.
The newly derived P8155 cell line had a higher incorporation than any of the established lines, and seemed to offer a good system for detailed study. In the P815S cultures, more labelled material was found in the medium than in the cells. Newly derived P815AS cells incorporated label at a low amount similar to the established lines and were not studied further. (Fig. 1) . In all cases, doubly labelled product was eluted from the column in the fractions that contained glycosaminoglycan standards. The doubly labelled materials from both P815Y and HC73 cells appeared as mixtures having some material (peak A) with a charge density similar to that of chondroitin sulphate and some material (peak B) with a charge density similar to that of heparin. The doubly labelled material (peak B) from X163 cells had a charge density similar to that of heparin. In addition, all three cell lines produced large amounts of 3H-labelled products, which were eluted from the DEAE-cellulose columns before standard hyaluronic acid. No [35S]sulphate was present in these fractions.
The labelled products found in the media of P815Y, X163, and HC73 cultures appeared to have elution patterns from DEAE-cellulose similar to those for the intracellular products. However, amounts were too small for accurate representation and these materials were not analysed further.
In a similar manner, [35S]sulphate-labelled materials from both the cells and medium of P815S cultures were chromatographed on DEAE-cellulose (Fig. 2) . Labelled materials from the cells had an elution pattern that was different from that of the medium, indicating significant charge-density differences between the intracellular and extracellular substances. The chromatographically separated 3H,35S-labelled glycosaminoglycans from the P815Y, X163 and HC73 cells were identified by enzymic degradation and hexosamine analysis ( None of the 3H-labelled products eluted from DEAE-cellulose before standard hyaluronic acid was degradable by testicular hyaluronidase or heparinase. No further identification was attempted. These products may be glycoprotein, as described in these cells by Thomas (1968) .
All of the sulphate-labelled materials from the cultures ofnewly derived P815S cells were degradable by chondroitinase ABC (Fig. 3) . The 35S-labelled glycosaminoglycan from the medium was degraded to a disaccharide product which co-chromatographed with ADi-4S, identifying the 3"S-labelled glycosaminoglycan as chondroitin 4-sulphate. (Fig. 4) was similar in size to the standard chondroitin 6-sulphate (mol.wt. approx. 40000), whereas the cellular material was smaller relative to this standard. Treatment of these materials with alkali did not alter their gel-filtration patterns. The apparent size difference between the chondroitin 4-sulphate of cells and the chondroitin 4-sulphate of the media would explain their different charge densities as shown by DEAEcellulose chromatography (Fig. 2) .
Culture conditions and glycosaminoglycan synthesis
Culture conditions and techniques were modified to ascertain the effects of several variables on glycosaminoglycan synthesis. These modifications included use of different growth media rather than Fischer's) and different serum supplement (foetal calf instead of horse serum). Cells were also studied for glycosaminoglycan synthesis before and after Wheldrake & Pasternak (1968) , in culture tubes.
Cells cultured in both ways were then tested for production of sulphated glycosaminoglycans. The results obtained with cells from the two types of cultures were compared with each other and with the results of our previous studies. These comparisons indicated no significant differences. 
Discussion
Differentiated normal mast cells are generally thought to synthesize only heparin as their glycosaminoglycan product. In contrast, it has been reported that neoplastic mast-cell tumours also contain significant amounts of chondroitin sulphate (Roden & Dorfman, 1959; Ringertz, 1963 A surprisingly small amount of total glycosaminoglycans was produced by the mastocytoma cells of the long-established P815Y, X163, and HC73 lines, as well as the newly established P815AS line. This amount is similar to that reported for numerous other cell types where biosynthesis of glycosaminoglycan is not an expected differentiated function. It is also considerably lower than the amounts previously reported for the cells of the P815Y (X-2) and X163 (X-1) lines (Green & Day, 1960) . Therefore, it seems likely that glycosaminoglycan production may no longer be a primary differentiated function of these lines of mastocytoma cells.
The newly derived P815S cells synthesized sulphated glycosaminoglycans in amounts considerably greater than the cells of the other tested lines. Unexpectedly, this glycosaminoglycan was found to be almost entirely chondroitin 4-sulphate. This apparently also represents a change in the differentiated function (heparin production) of this line. The chondroitin 4-sulphate found in the medium of the P815S cell cultures appeared to be larger than 1973
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